Congratulations to Professor Krishna Chatterjee, a consultant endocrinologist at Addenbrooke's - awarded a CBE in the King's New Year Honours for his groundbreaking work on endocrine disorders.
This represents the efforts of many clinical and scientist colleagues in the University, CUH and our NIHR Clinical Research Facility.
Professor Krishna Chatterjee
Alongside his work at Cambridge University Hospitals NHS Foundation Trust (CUH), Krishna Chatterjee is a professor of endocrinology at the University of Cambridge.
He is also director of the NIHR Clinical Research Facility in Cambridge and led the COVBOOST vaccine trial locally during the pandemic
He is well known for discoveries of genetic disorders of thyroid gland formation, the regulation of hormone synthesis and hormone action.
These have changed our understanding of the hypothalamic-pituitary-thyroid axis.
He said:
“I am delighted that our work has been recognised in this way. This also represents the efforts of many clinical and scientist colleagues in the University, CUH and our NIHR Clinical Research Facility, with whom I have worked over many years.
"Together with the patients participating in our research, we strive to continue advancing knowledge and health outcomes in endocrine disorders.”
Prof Chatterjee’s research group is focused on genetic and molecular endocrinology, exploring disorders including resistance to thyroid hormone (RTH) and PPARgamma gene defects associated with lipodystrophic insulin resistance.
Prof Chatterjee showed how deficiency of human selenocysteine-containing proteins leads to a multisystem disease, including disordered thyroid hormone metabolism, and works on translating his discoveries to improve diagnosis and treatment of thyroid conditions.
